US Patent 11952397 Crystalline forms of a neuroactive steroid
Patent 11952397 was granted and assigned to SAGE Therapeutics on April, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 2, 2023
0
Date of Patent
April 9, 2024
0
Patent Applicant
Patent Application Number
18363942
0
Patent Inventor Names
Tianrui Li
0
Shanming Kuang
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11952397 Crystalline forms of a neuroactive steroid
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
